PGY2 Oncology Fontana-Riverside, California

The Kaiser Permanente Inland Empire PGY2 Oncology Pharmacy Residency is a dynamic and innovative 52 week (12-month) program designed to transition PGY1 graduates from generalist practice to advanced, specialized practice in oncology.
Residents will gain direct patient care experience across a wide spectrum of over 15 common malignancies, including but not limited to:
• Breast Cancer
• Colorectal Cancer
• Acute and Chronic Leukemias
• Lung Cancer
• Lymphomas
• Ovarian Cancer
• Prostate Cancer

Our program offers exposure to a diverse patient population, from pediatrics to adults, and includes hands-on experience managing cancer-related and treatment-related conditions such as:
• Antiemetic therapy
• Pain management
• Myelosuppression
• Infectious disease management in immunocompromised patients

Residents will also explore cutting-edge oncology practices, including:
• Clinical research and investigational drug trials
• Stem cell therapy
• Radiation therapy and surgical oncology

Additional training includes oncology drug information services and electronic health record chemotherapy treatment plan development.

This residency offers a robust and supportive learning environment within one of the nation’s leading integrated healthcare systems, preparing residents to become confident, compassionate, and highly skilled oncology pharmacy practitioners.

---

Pharmacy Services

We have 7 licensed oncology pharmacies: 3 licensed oncology pharmacies in Fontana, and 4 pharmacies in Riverside. Our services include outpatient oncology infusions, inpatient chemotherapy management, pharmacy driven protocols such as carboplatin per pharmacy dosing, electrolyte management, erythropoietin stimulating factor management, and oral chemotherapy management. We work in collaboration with physicians, nursing, and researchers to provide exceptional services for our patients

Riverside At A Glance

Fontana At A Glance

 

---

Learning Experiences

Required Learning Experiences

• Fontana Adult Hematology-Oncology – 9 weeks
• Fontana Pediatric Hematology-Oncology – 8 weeks
• Oncology Pharmacy Drug Intelligence & Strategy (DIS) and Beacon Module – 6 weeks
• Oncology Pharmacy Practice Management – 2 weeks
• Oncology Research – 1 week
• Ontario-Vineyard Adult Hematology-Oncology – 8 weeks
• Orientation – 4 weeks
• Riverside – Oral Chemotherapy Clinic – 8 weeks
• City of Hope – Bone Marrow Transplant – 2 weeks

Required Longitudinal Learning Experiences

• Western States Conference Project

Elective Learning Experiences

• Residents may extend an existing rotation or ask to start a new rotation that is not listed (dependent on availability)

---

Requirements for Acceptance

• Must have completed an ASHP accredited or candidate-status PGY1 residency Program prior to start of program.
• Must be licensed as an Intern Pharmacist in the state of California by the first day of residency program if not already licensed as a pharmacist in California.
• Resident must be a licensed California pharmacist within 120 days from the program start date. Residents who are not licensed as a pharmacist within 120 days from the program start date will have their term of appointment extended by the number of days the resident is without licensure past the 120-day deadline up to a maximum of 45 days. Failure to obtain a California state pharmacist license within 165 days from the program start date will result in the resident being dismissed from the program and employment will be terminated.
• To be eligible for pharmacist licensure, candidates must be graduates or candidates for graduation from an ACPE accredited degree program (or one in the process of pursuing accreditation) or have a Foreign Pharmacy Graduate Examination Committee (FPGEC) certificate from the NABP.
• For more information regarding licensing in California, please visit www.pharmacy.ca.gov
• Certifications (If applicable): BLS, ACLS
• Candidates must be registered in the National Matching Services, Inc. (NMS).
• Candidates must participate in the ASHP Matching Program.
• Program NMS Code: 617460 and ASHP Program Code: 92007

---

Application Requirements

For letter of recommendations: highly encourage references to add specific details about applicant to Open Box comments (can be in format of traditional letter)

• Statement of Interest/Letter of Intent
• Curriculum Vitae
• Official Pharmacy School transcripts, sent directly from the applicant’s college or school of pharmacy
• Three letters of references/recommendations utilizing the form in PhORCAS is required for all reference writers.
• For letter of recommendations: highly encourage references to add specific details about applicant to Open Box comments (can be in format of traditional letter)
• Application Deadline: January 12, 2026

---

Interview Details

• On-Site Interview Required: Yes
• On-Site Interview Dates: Jan-Feb 2026
• Open House – Virtual – TBD
• Click here to link to the Virtual Information Sessions:
  • October 22, 2025 – 1p.m. – 2p.m. PST
  • November 13, 2025 – 1p.m. – 2p.m. PST
  • December 17, 2025 – 3p.m. – 4p.m. PST

**This residency agrees that no person at this residency will solicit, accept, or use any ranking-related information from any residency applicant**

Back to all programs